Cargando…
Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units
INTRODUCTION: Methicillin-resistant Staphylococcus aureus (MRSA) causes severe morbidity and mortality in intensive care units (ICUs) worldwide. The purpose of this study was to determine whether intranasal mupirocin prophylaxis is useful to prevent ICU-acquired infections with MRSA. MATERIALS AND M...
Autores principales: | Muller, Arno, Talon, Daniel, Potier, Alexandre, Belle, Evelyne, Cappelier, Gilles, Bertrand, Xavier |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175886/ https://www.ncbi.nlm.nih.gov/pubmed/15987397 http://dx.doi.org/10.1186/cc3512 |
Ejemplares similares
-
Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
por: Wertheim, Heiman FL, et al.
Publicado: (2005) -
Association of Staphylococcus aureus Colonization with the Evolving Neonatal Nasal Microbiome and the Impact of Intranasal Mupirocin
por: Khamash, Dina, et al.
Publicado: (2017) -
Estimated Methicillin-Resistant Staphylococcus aureus Decolonization in Intensive Care Units Associated With Single-Application Chlorhexidine Gluconate or Mupirocin
por: Lofgren, Eric T., et al.
Publicado: (2021) -
Antimicrobial Stewardship Lessons From Mupirocin Use and Resistance in Methicillin-Resitant Staphylococcus Aureus
por: Peterson, Lance R., et al.
Publicado: (2017) -
NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus
por: Mercer, Derry K., et al.
Publicado: (2017)